Transforming the future of hypertension care
Aktiia’s mission expands far beyond monitoring – to foster new opportunities in evaluation, treatment, and yielding never before possible insights.
Aktiia Healthcare Solution
Transforming the future of hypertension care
Aktiia’s mission expands far beyond monitoring – to foster new opportunities in evaluation, treatment, and yielding never before possible insights.
Aktiia demonstrates validated accuracy
Aktiia’s pivotal trial has proven Aktiia is as accurate as a cuff:2
- In multiple body positions including sitting, lying and standing
- Across Fitzpatrick skin tones 1-6
- From low to high density follicle density
CE Marked class IIa medical device5
Systolic BP Accuracy: 0.45 ± 7.75 mmHg2
Diastolic BP Accuracy: 0.38 ± 6.86 mmHg2
Take a closer look at Aktiia’s Healthcare Platform
Request a DemoBased on over 20 years
of research
Aktiia believes in complete transparency of our clinical trials. With over 100 peer-reviewed publications, Aktiia partners with global experts in the mission to transform hypertension.
Read a selection of our publications:
World’s largest BP dataset with 300 million data points1
Learn More
Learn More
Discover more how our hypertension specialists can help your project
contact us todayHow to manage what is not measured?
30% of adults suffer from hypertension8
46% of adults with hypertension
are unaware that they have the condition8
75% of adults with hypertension do not measure their blood pressure weekly9
80% of those diagnosed do not have it under control.8
Resulting in the loss of 18 million lives each year as the leading cause of heart attack and stroke. At a cost of $370 billion per year, this is not sustainable.10
1 Aktiia Bracelet Clinical Motion Study. 2022.
2 Sola et al. Nature Scientific Reports. (2021) https://doi.org/10.1038/s41598-021-99294-w
3 After initial (2) months of use
4 Aktiia (2022) Product data. Unpublished.
5 Aktiia Bracelet G1 has been CE-marked under the Medical Device Regulation (EU)2017/745 as a class IIa medical device.
6 ISO81060-2 Criterion 1 requires the mean difference of test versus reference blood pressure measurements for both systolic and diastolic blood pressure to be less than 5 mmHg, with a standard deviation of less than 8 mmHg.
7 Aktiia (2022) Product data.
8 World Hypertension Day.” World Health Organization, https://www.who.int/news-room/fact-sheets/detail/hypertension. 23 Jan 2023.
9 Ostchega at al. Factors Associated with Home Blood Pressure Monitoring Among US Adults. American Journal of Hypertension. 2017
10 P Muntner et al. Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018. JAMA. 2020;324(12):1190-1200.
11 American Heart Association, “2022 Heart Disease & Stroke Statistical Update Fact Sheet Global Burden of Disease”